Dexmedetomidine versus propofol-opioid for sedation in transcatheter aortic valve implantation patients: a retrospective analysis of periprocedural gas exchange and hemodynamic support

ConclusionsIn sedated TAVI patients, DEX was associated with lower PaCO2 values and reduced requirements for vasopressor support, making it a promising alternative to PO for sedation during TAVI.Trial registrationwww.ClinicalTrials.gov (NCT01390675). Registered 11 July 2011.
Source: Canadian Journal of Anesthesia - Category: Anesthesiology Source Type: research